TherapeuticsMD
TXMD
#10170
Rank
โ‚น1.72 B
Marketcap
โ‚น149.26
Share price
-0.60%
Change (1 day)
59.74%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2025 (TTM): -โ‚น4.15

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is -โ‚น4.47. In 2021 the company made an earnings per share (EPS) of -โ‚น1,940 an increase over its 2020 EPS that were of -โ‚น2,994.

EPS history for TherapeuticsMD from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.15
2021-โ‚น1,940-35.22%
2020-โ‚น2,994-5.63%
2019-โ‚น3,17320.34%
2018-โ‚น2,63755.26%
2017-โ‚น1,698-19.15%
2016-โ‚น2,100-6%
2015-โ‚น2,23442.86%
2014-โ‚น1,56452.17%
2013-โ‚น1,028

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Agile Therapeutics
AGRX
-โ‚น345.90 7,640.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-โ‚น2,260 50,460.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น153.73-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น120.83-2,803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น157.87-3,632.58%๐Ÿ‡ฌ๐Ÿ‡ง UK